blog_posts: 6d6fd60f92
This data as json
id | createdDate | title | link | postExcerpt | featuredImageUrl | hash | contributors | modifiedDate | displayDate |
---|---|---|---|---|---|---|---|---|---|
blog-posts#53-2848 | 2020-10-07 19:42:20 | Conducting end-to-end pharmacovigilance workflows using AWS technologies | https://aws.amazon.com/blogs/industries/conducting-end-to-end-pharmacovigilance-workflows-using-aws-technologies/ | Introduction Bio-pharmaceutical companies have always had a responsibility to report adverse events (AE), whether in clinical development or post market-approval scenarios, to the Food and Drug Administration (FDA). The COVID-19 pandemic and the race to find effective treatments for this disease has caused both the FDA and bio-pharmaceutical organizations around the world to re-imagine the [...] | https://d2908q01vomqb2.cloudfront.net/c5b76da3e608d34edb07244cd9b875ee86906328/2020/10/06/Pharmacovigilance-small-300x200.jpeg | 6d6fd60f92 | Patrick Buckner, Deven Atnoor, Ph.D, Mayank Thakkar | 2021-09-14 23:48:27 | 07 Oct 2020 |
Links from other tables
- 11 rows from blog_post_hash in blog_post_tags